UB Paderborn / Katalog / Suche / in CDI

On the Isometry Groups of Invariant Lorentzian Metrics on the Heisenberg Group

Mediterranean journal of mathematics, 2014-02, Vol.11 (1), p.137-153

2014

Link zum Volltext

Verfügbarkeit prüfen

Expression of high p53 levels in colorectal cancer: a favourable prognostic factor

British Journal of Cancer, 1999-09, Vol.81 (1), p.122-126

1999

Link zum Volltext

Verfügbarkeit prüfen

Loss of Heterozygosity on the Short Arm of Chromosome 3 in Renal Cancer

Oncology, 2000-01, Vol.59 (2), p.126-130

2000

Link zum Volltext

Verfügbarkeit prüfen

Loss of heterozygosity and methylation of p16 in renal cell carcinoma

Urolithiasis, 2003-07, Vol.31 (3), p.159-162

2003

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of the quantified expression of p185 in non-small cell lung cancer

The Journal of thoracic and cardiovascular surgery, 2000-06, Vol.119 (6), p.1119-1125

2000

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of the quantified expression of p185c-erbb2 in non–small cell lung cancer

The Journal of thoracic and cardiovascular surgery, 2000-06, Vol.119 (6), p.1119-1125

2000

Link zum Volltext

Verfügbarkeit prüfen

Use of Possible Synergistic Expression of p53 and p185 as a Prognostic Tool for Stage I Non‐small‐cell Lung Cancer

World journal of surgery, 1999-12, Vol.23 (12), p.1294-1300

1999

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of cathepsin D in breast cancer (BC) patients

European journal of cancer (1990), 1999-09, Vol.35, p.S92-S92

1999

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of the quantified expression of p185c-erbB2in non-small cell lung cancer

The Journal of thoracic and cardiovascular surgery, 2000, Vol.119 (6), p.1119-1125

2000

Link zum Volltext

Verfügbarkeit prüfen

Use of possible synergistic expression of p53 and p185 as a prognostic tool for stage I non-small-cell lung cancer. Commentary

World journal of surgery, 1999, Vol.23 (12), p.1294-1300

1999

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of heterozygosity loss in chromosome 3p in non-microcytic bronchogenic carcinoma

Medicina clínica, 1999-04, Vol.112 (14), p.527

1999

Link zum Volltext

Verfügbarkeit prüfen

5'CpG island methylation of the suppressor gene p16/CDKN2/MTS1 in renal carcinoma

Archivos españoles de urología, 2000-06, Vol.53 (5), p.417

2000

Link zum Volltext

Verfügbarkeit prüfen

Loss of heterozygosity in the 9p21 region as an inactivation mechanism of the p16 suppressor gene

Archivos españoles de urología, 2000-09, Vol.53 (7), p.603

2000

Link zum Volltext

Verfügbarkeit prüfen

P185 (Neu) oncoprotein in the prognosis of bladder carcinoma. Experience of 5 years

Archivos españoles de urología, 2000-04, Vol.53 (3), p.238

2000

Link zum Volltext

Verfügbarkeit prüfen

Quantification of p53 oncoprotein in bladder carcinoma: 5-year experience

Archivos españoles de urología, 1999-04, Vol.52 (3), p.220

1999

Link zum Volltext

Verfügbarkeit prüfen

The loss of heterozygosity on the short arm of chromosome 3 in renal carcinoma

Archivos españoles de urología, 1999-01, Vol.52 (1), p.3

1999

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: a randomized controlled trial

BMC pediatrics, 2019-10, Vol.19 (1), p.361-361, Article 361

2019

Link zum Volltext

Verfügbarkeit prüfen

Kdm1a safeguards the topological boundaries of PRC2-repressed genes and prevents aging-related euchromatinization in neurons

Nature communications, 2024-03, Vol.15 (1), p.1781-1781, Article 1781

2024

Link zum Volltext

Verfügbarkeit prüfen

Changes in dietary intake, plasma carotenoids and erythrocyte membrane fatty acids in breast cancer survivors after a lifestyle intervention: results from a single‐arm trial

Journal of human nutrition and dietetics, 2019-08, Vol.32 (4), p.468-479

2019

Link zum Volltext

Verfügbarkeit prüfen

High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice

Current biology, 1998-10, Vol.8 (21), p.1169-1178

1998

Link zum Volltext

Verfügbarkeit prüfen

Omnidirectional high-reflectivity mirror in the 4–20 μ m spectral range

Journal of optics (2010), 2017-06, Vol.19 (6), p.65102

2017

Link zum Volltext

Verfügbarkeit prüfen

268P Results from a real-world study of patients (pts) with hormone-receptor (HR)-positive HER2-negative metastatic breast cancer (MBC) treated with CDK4/6 inhibitors (CDK 4/6i) in three institutions

Annals of oncology, 2022-09, Vol.33, p.S660

2022

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity of COVID-19 vaccines in lung cancer patients

Lung cancer (Amsterdam, Netherlands), 2023-10, Vol.184, p.107323-107323, Article 107323

2023

Link zum Volltext

Verfügbarkeit prüfen

Relativistic tunnelling time for electronic wave packets

Journal of physics. A, Mathematical and theoretical, 2011-01, Vol.44 (1), p.015303-12

2011

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

On the Isometry Groups of Invariant Lorentzian Metrics on the Heisenberg Group

Expression of high p53 levels in colorectal cancer: a favourable prognostic factor

Loss of Heterozygosity on the Short Arm of Chromosome 3 in Renal Cancer

Loss of heterozygosity and methylation of p16 in renal cell carcinoma

Prognostic value of the quantified expression of p185 in non-small cell lung cancer

Prognostic value of the quantified expression of p185c-erbb2 in non–small cell lung cancer

Use of Possible Synergistic Expression of p53 and p185 as a Prognostic Tool for Stage I Non‐small‐cell Lung Cancer

Prognostic value of cathepsin D in breast cancer (BC) patients

Prognostic value of the quantified expression of p185c-erbB2in non-small cell lung cancer

Use of possible synergistic expression of p53 and p185 as a prognostic tool for stage I non-small-cell lung cancer. Commentary

Prognostic value of heterozygosity loss in chromosome 3p in non-microcytic bronchogenic carcinoma

5'CpG island methylation of the suppressor gene p16/CDKN2/MTS1 in renal carcinoma

Loss of heterozygosity in the 9p21 region as an inactivation mechanism of the p16 suppressor gene

P185 (Neu) oncoprotein in the prognosis of bladder carcinoma. Experience of 5 years

Quantification of p53 oncoprotein in bladder carcinoma: 5-year experience

The loss of heterozygosity on the short arm of chromosome 3 in renal carcinoma

Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: a randomized controlled trial

Kdm1a safeguards the topological boundaries of PRC2-repressed genes and prevents aging-related euchromatinization in neurons

Changes in dietary intake, plasma carotenoids and erythrocyte membrane fatty acids in breast cancer survivors after a lifestyle intervention: results from a single‐arm trial

High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice

Omnidirectional high-reflectivity mirror in the 4–20 μ m spectral range

678P Real-world evidence of first-line cetuximab (CX) plus paclitaxel (PX) in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)

268P Results from a real-world study of patients (pts) with hormone-receptor (HR)-positive HER2-negative metastatic breast cancer (MBC) treated with CDK4/6 inhibitors (CDK 4/6i) in three institutions

Immunogenicity of COVID-19 vaccines in lung cancer patients

Relativistic tunnelling time for electronic wave packets

Suchergebnisse filtern